Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: Plasma concentrations exceed target levels, with drug accumulation in the most severe patients

Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: Plasma concentrations exceed target levels, with drug accumulation in the most severe patients

<p><strong>Background:</strong><br /> TKM-130803 is a specific anti-EBOV therapeutic comprised of two small interfering RNAs (siRNA) siLpol-2 and siVP35-2. The pharmacokinetics (PK) of these siRNAs was defined in Ebola virus disease (EVD) patients, with reference to efficacy...

Bibliografski detalji
Glavni autori:	Scott, JT, Sharma, R, Meredith, LW, Dunning, J, Moore, CE, Sahr, F, Ward, S, Goodfellow, I, Horby, P
Daljnji autori:	RAPIDE-TKM Trial Team
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2020

Slični predmeti

Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean patients
od: Scott, JT, i dr.
Izdano: (2019)

Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean subjects
od: Scott, J, i dr.
Izdano: (2020)

Experimental treatment of Ebola virus disease with TKM-130803: A single-arm phase 2 clinical trial.
od: Dunning, J, i dr.
Izdano: (2016)

Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial
od: Dunning, J, i dr.
Izdano: (2016)

Surviving Ebola: A historical cohort study of Ebola mortality and survival in Sierra Leone 2014-2015
od: Wing, K, i dr.
Izdano: (2018)

Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases
od: Arias, A, i dr.
Izdano: (2016)

Enhanced case management can be delivered for patients with EVD in Africa: Experience from a UK military Ebola treatment centre in Sierra Leone.
od: Dickson, SJ, i dr.
Izdano: (2017)

Building resilient health systems: experimental evidence from Sierra Leone and the 2014 Ebola outbreak
od: Christensen, D, i dr.
Izdano: (2020)

Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic
od: Rojek, A, i dr.
Izdano: (2017)

Do Patients Perceptions Exceed Their Expectations In Private Healthcare Settings?
od: Norazah Mohd Suki, i dr.
Izdano: (2011)

Insights from clinical research completed during the west Africa Ebola virus disease epidemic
od: Rojek, A, i dr.
Izdano: (2017)

Treating Ebola in eastern DRC
od: Rojek, AM, i dr.
Izdano: (2020)

Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone
od: Camacho, A, i dr.
Izdano: (2016)

Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections
od: Rojek, A, i dr.
Izdano: (2017)

Inside sierra
Izdano: (1988)

Ebola virus antibody decay–stimulation in a high proportion of survivors
od: Adaken, C, i dr.
Izdano: (2021)

PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
od: Forsyth, D, i dr.
Izdano: (1989)

Memasyarakatkan komunikasi maklumat (TKM) menerusi Projek E-Komuniti: yakin boleh?
od: Rahmah Hashim,
Izdano: (2000)

Ebola disease: bridging scientific discoveries and clinical application
od: Rojek, A, i dr.
Izdano: (2024)

The UK's multidisciplinary response to an Ebola epidemic
od: Reece, S, i dr.
Izdano: (2017)

Experimental treatment of Ebola virus disease with brincidofovir
od: Dunning, J, i dr.
Izdano: (2016)

Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014.
od: de Jong, M, i dr.
Izdano: (2014)

Metagenomic investigation of co-infections of Ebola virus disease and Lassa fever patients
od: Krasilnikova, Lydia A
Izdano: (2016)

Teaching research methodology within an Ebola virus outbreak.
od: Hope-Gill, B, i dr.
Izdano: (2016)

School construction in Sierra Leone
od: Rodríguez-Noyola, Joanna
Izdano: (2011)

Sierra Leone and the 'stranger problem'
od: Sutherland, A
Izdano: (1977)

Reflecting on Liberia and Sierra Leone
od: Okello, J
Izdano: (2016)

Ebola vaccination
od: Fitzgerald, F, i dr.
Izdano: (2015)

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
od: Abd. Rahman, Nurul Azrin, i dr.
Izdano: (2013)

Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
od: Simpson, J, i dr.
Izdano: (1999)

Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.
od: Aronson, J
Izdano: (1983)

A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic
od: Rojek, A, i dr.
Izdano: (2019)

Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies
od: van Griensven, J, i dr.
Izdano: (2016)

The Agta of Northeastern Sierra Madre : photographs
Izdano: (2000)

Exceedance Problems For Critical Branching Processes.
od: Hasan, Husna, i dr.
Izdano: (2005)

Crotonases: Nature’s exceedingly convertible catalysts
od: Lohans, C, i dr.
Izdano: (2017)

Occurrence of exceedances in a finite perpetuity
od: Benjamin, N, i dr.
Izdano: (2004)

Clients and consultants : meeting and exceeding expectations /
od: Bell, Chip R., i dr.
Izdano: (1985)

Management : meeting and exceeding customer expectations /
od: Plunkett, W. Richard (Warren Richard), i dr.
Izdano: (2002)

Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit
od: Abdul-Aziz, M.H., i dr.
Izdano: (2015)